General
Preferred name
SPIPERONE
Synonyms
SPIPERONE HYDROCHLORIDE ()
Spiroperidol ()
Spiropitan ()
[3H]spiperone ()
[3H]spiperone ()
R 5147 ()
R-5147 ()
NSC-170983 ()
P&D ID
PD001491
CAS
749-02-0
2022-29-9
Tags
natural product
drug
available
First approval
1969
Drug indication
Discovery agent
Antipsychotic
Drug Status
investigational
approved
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Selective D2 dopamine receptor antagonist. (LOPAC library)
DESCRIPTION 5-HT2A antagonist. Also D2-like antagonist (Tocriscreen Total)
DESCRIPTION Spiperone hydrochloride is a 5-HT2A and selective dopamine D2 receptor antagonist (Ki = 0.06, 0.6, 0.08, ~ 350, ~ 3500 nM for D2, D3, D4, D1 and D5 receptors, respectively) used as an antipsychotic. It also acts as an activator of calcium-activated chloride channels (EC50 = 9.3 µM). (BOC Sciences Bioactive Compounds)
Cell lines
0
Organisms
4
Compound Sets
23
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocriscreen Total
External IDs
37
Properties
(calculated by RDKit )
Molecular Weight
395.2
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
2
cLogP
3.22
TPSA
52.65
Fraction CSP3
0.39
Chiral centers
0.0
Largest ring
6.0
QED
0.76
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
D2
Pathway
GPCR/G protein
Neuroscience
Neuronal Signaling
Target
dopamine
ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7
5-HT Receptor
Dopamine Receptor
Indication
schizophrenia
MOA
Dopamine Receptor antagonist
Source data